S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

VRPX Virpax Pharmaceuticals Inc

0.1835

-0.0064 (-3.37%)

Last Updated: 14:53:44

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Virpax Pharmaceuticals (NASDAQ:VRPX)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Virpax Pharmaceuticals Charts.

Virpax Pharmaceuticals (NASDAQ:VRPX)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Virpax Pharmaceuticals Charts.

Virpax Pharmaceuticals Inc News

Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology
Thursday 27 February 2025 (2 weeks ago) • Business Wire

Virpax Confirms Positive Results with US Army with Probudur™ for Combat Care Study
Thursday 13 February 2025 (4 weeks ago) • Business Wire

Form 8-K - Current report
Thursday 6 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 4 February 2025 (1 month ago) • Edgar (US Regulatory)

Virpax's Matthew Barnes to Present at Outsourcing in Clinical Trials Conference
Friday 31 January 2025 (1 month ago) • Business Wire

Form 8-K - Current report
Thursday 30 January 2025 (1 month ago) • Edgar (US Regulatory)

Spartan Capital Securities Serves as Sole Placement Agent in Virpax Pharmaceuticals’ $6 Million Follow-On Offering
Thursday 30 January 2025 (1 month ago) • GlobeNewswire Inc.

Virpax Pharmaceuticals, Inc. Announces Closing of $6.0 Million Public Offering of Common Stock and Pre-Funded Warrants
Thursday 30 January 2025 (1 month ago) • Business Wire

Form 424B4 - Prospectus [Rule 424(b)(4)]
Tuesday 28 January 2025 (1 month ago) • Edgar (US Regulatory)

Virpax Pharmaceuticals, Inc. Announces Pricing of $6 Million Public Offering of Common Stock and Pre-Funded Warrants
Tuesday 28 January 2025 (1 month ago) • Business Wire

Form EFFECT - Notice of Effectiveness
Monday 27 January 2025 (1 month ago) • Edgar (US Regulatory)

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Friday 17 January 2025 (2 months ago) • Edgar (US Regulatory)

More Virpax Pharmaceuticals Inc News Articles

Leonteq Securities

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions